Active clinical trials:

1. Prostate cancer – open recruitment

This study is intended for patients with metastatic castration-resistant prostate cancer.

2. Prurigo nodularis – open enrollment

Trial for patients (aged 18–75) with prurigo nodularis

3. Breast cancer – open enrollment

Trial for patients with HER2-negative advanced/metastatic breast cancer

4. Breast cancer – open enrollment

Trial for patients with hormone receptor-positive and HER2-negative advanced/metastatic breast cancer whose disease progressed after prior CDK4/6 inhibitor-based therapy

5. Lung cancer – open enrollment

Trial for patients with previously treated non-small cell lung cancer (NSCLC) with a positive PD-L1 response

6. Ovarian cancer – open enrollment

Trial for patients with serous ovarian, fallopian tube, or high-stage primary peritoneal cancer

7. Atopic dermatitis Skin – open enrollment

Study aimed at adult patients with atopic dermatitis

8. Acne vulgaris – closed enrollment

Study aimed at patients (women and men aged 9-50) with acne vulgaris

9. Knee osteoarthritis – closed enrollment

Study aimed at patients with knee osteoarthritis

10. Breast cancer – closed enrollment

Study aimed at patients with estrogen receptor-positive and Her2-negative breast cancer whose disease progressed after prior endocrine treatment for advanced disease

11. Renal cell carcinoma – closed enrollment

Study aimed at patients with unresectable and locally advanced or metastatic papillary renal cell carcinoma

12. Plaque psoriasis – closed enrollment

Study aimed at adult participants with moderate to severe psoriasis

13. Ovarian cancer – closed recruitment

Study intended for patients with platinum-resistant ovarian cancer

14. Ovarian cancer – closed recruitment

Study intended for patients with epithelial ovarian cancer with a BRCA mutation and/or homologous recombination deficiency (HRD) who have progressed on prior PARP inhibitor therapy

15. Solid tumors – closed recruitment

Study intended for patients with locally advanced or metastatic solid tumors

Clinical trials in the registration phase:

1. Atopic Dermatitis

Study for adult patients with moderate to severe atopic dermatitis

2. Lupus Erythematosus

Study for patients with active skin manifestations of lupus erythematosus, with or without systemic disease, receiving standard care

3. Cancer Cachexia

Study for patients with cancer cachexia

4. Prostate Cancer

Study for patients with castration-resistant prostate cancer (CRPCC)

If you are interested in participating in the above mentioned clinical trials free of charge, please contact us by phone: 12 340 24 02

Clinical trials are conducted to assess the effectiveness and safety of a given drug, medical device (e.g. diagnostic equipment) or other medical technology (e.g. surgery). Most often, research concerns new or already known drugs, but evaluated for new applications. Clinical trials are one of the key elements of medical progress.
 

The research is carried out at the request of international pharmaceutical companies, usually before the medicine is released for sale. Therefore, research participants may have access to new generations of medicinal products often many years before they enter the market.
 

Each person who participates in a clinical trial gives the opportunity to improve health and life not only for themselves but in the future also for many other patients suffering from similar diseases.
 

Benefits of participating in clinical trials:

• active participation in improving one's health and life
• access to innovative treatments not available on the market
• top-quality free medical care
• helping other patients by actively contributing to the development of medicine

Some tests are performed on people with a specific disease, while others on participants who are completely healthy. Only a person who meets the pre-defined requirements can participate in a given study. Study participants are volunteers and do not receive financial rewards for participating in the study. In return, all examinations, medical visits and drug samples are free.

The key element in clinical trials is the participant's safety and protection of his rights. The tests are carried out in accordance with the test protocol, which in each case is approved by an independent Bioethical Committee. In our center, all tests are conducted in accordance with the principles of Good Clinical Practice (GCP) and ethical principles contained in the Helsinki Declaration